» Articles » PMID: 36706195

Malassezia Restricta Promotes Alcohol-induced Liver Injury

Overview
Journal Hepatol Commun
Specialty Gastroenterology
Date 2023 Jan 27
PMID 36706195
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic alcohol consumption is associated with intestinal fungal dysbiosis, yet we understand little about how alterations of intestinal fungi (mycobiota) contribute to the pathogenesis of alcohol-associated liver disease. By reanalyzing internal transcribed spacer 2 amplicon sequencing of fecal samples from a cohort of 66 patients with alcohol use disorder for presence (as opposed to relative abundance) of fungal species, we observed that the presence of Malassezia restricta was associated with increased markers of liver injury. M. restricta exacerbates ethanol-induced liver injury both in acute binge and chronic ethanol-feeding models in mice. Using bone marrow chimeric mice, we found that the disease exacerbating effect by M. restricta was mediated by C-type lectin domain family 4, member N on bone marrow-derived cells. M. restricta induces inflammatory cytokines and chemokines in Kupffer cells through C-type lectin domain family 4, member N signaling. Targeting fungal pathobionts might be a therapeutic strategy for alcohol-associated liver disease.

Citing Articles

The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease.

Huang H, Wang Q, Yang Y, Zhong W, He F, Li J Gut Microbes. 2024; 16(1):2440111.

PMID: 39676474 PMC: 11651280. DOI: 10.1080/19490976.2024.2440111.


Global research trends and hotspots on human intestinal fungi and health: a bibliometric visualization study.

Gong M, Yu H, Qu H, Li Z, Liu D, Zhao X Front Cell Infect Microbiol. 2024; 14:1460570.

PMID: 39483119 PMC: 11525014. DOI: 10.3389/fcimb.2024.1460570.


A New Generation of Postbiotics for Skin and Scalp: In Situ Production of Lipid Metabolites by .

Pagac M, Gempeler M, Campiche R Microorganisms. 2024; 12(8).

PMID: 39203553 PMC: 11357556. DOI: 10.3390/microorganisms12081711.


Gut mycobiome alterations and implications for liver diseases.

Zeng S, Schnabl B PLoS Pathog. 2024; 20(8):e1012377.

PMID: 39116092 PMC: 11309506. DOI: 10.1371/journal.ppat.1012377.


Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease.

Jiang S, Xu L, Chen Y, Shu Z, Lv L, Zhao Y Sci China Life Sci. 2024; 67(6):1183-1198.

PMID: 38413553 DOI: 10.1007/s11427-023-2458-1.